Haloemodins, a new class of endothelin-1 type B (ETB) receptor binding inhibitors.
Shu
Y Z
YZ
Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492.
Arcuri
M
M
Kozlowski
M R
MR
Wang
R R
RR
Lam
K S
KS
Chang
L P
LP
Pirnik
D M
DM
Rose
P M
PM
D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D004642:Emodin / Q000031:analogs & derivatives / Q000494:pharmacology*; D065128:Endothelin Receptor Antagonists; D006801:Humans; D017466:Receptors, Endothelin / Q000502:physiology; D013329:Structure-Activity Relationship
D065128:Endothelin Receptor Antagonists; D017466:Receptors, Endothelin; D004642:Emodin